Profile data is unavailable for this security.
About the company
Astena Holdings Co Ltd, formerly Iwaki & Co Ltd is a Japan-based company primarily engaged in the fine chemicals business, medical business, health & beauty care (HBC) and food business, and industrial chemicals business. The Company operates through four business segments. The Fine Chemicals segment is engaged in manufacture and sale of pharmaceutical raw materials and pharmaceuticals. The Medical segment is engaged in the manufacturing and sales of pharmaceutical products. The HBC and Food segment is engaged in the manufacture and sale of cosmetic raw materials, functional food raw materials, general use medicines and related products, as well as cosmetics. The Industrial Chemicals segment manufactures and sells chemicals for electronic industries, surface treatment chemicals, chemical products, surface treatment chemical raw materials, as well as to printed circuit board and other manufacturing plants. The other businesses include consulting services and others.
- Revenue in JPY (TTM)53.39bn
- Net income in JPY2.09bn
- Incorporated1941
- Employees1.40k
- LocationAstena Holdings Co Ltd4-8-2, Nihombashi Hon-choCHUO-KU 103-8403JapanJPN
- Phone+81 332790481
- Fax+81 332713240
- Websitehttps://www.astena-hd.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbio Pharmaceuticals Ltd | 3.07bn | -4.02bn | 10.74bn | 109.00 | -- | 2.08 | -- | 3.50 | -92.13 | -92.13 | 70.03 | 112.55 | 0.4225 | 2.97 | 4.47 | 28,137,370.00 | -55.36 | -19.18 | -62.58 | -23.62 | 77.57 | 65.84 | -131.05 | -24.32 | 6.51 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Ohki Healthcare Holdings Co Ltd | 342.45bn | 1.87bn | 12.27bn | 632.00 | 6.40 | 0.3983 | 8.10 | 0.0358 | 136.22 | 136.22 | 24,995.05 | 2,189.15 | 2.45 | 12.90 | 4.52 | 541,849,700.00 | 1.29 | 1.85 | 5.54 | 8.42 | 5.00 | 6.16 | 0.5268 | 0.7178 | 0.8641 | -- | 0.2547 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| Stella Pharma Corp | 284.89m | -726.61m | 16.95bn | 44.00 | -- | 5.50 | -- | 59.49 | -22.94 | -22.94 | 8.91 | 90.49 | 0.061 | 0.0433 | 2.59 | 6,474,773.00 | -15.55 | -22.50 | -16.34 | -24.83 | 84.75 | -- | -255.05 | -488.65 | 17.82 | -563.58 | 0.217 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| CellSeed Inc | 199.47m | -957.04m | 17.02bn | 35.00 | -- | 7.76 | -- | 85.31 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.21bn | 17.24bn | 11.00 | -- | 6.94 | -- | -- | -67.63 | -67.63 | 0.00 | 129.88 | 0.00 | -- | -- | 0.00 | -53.54 | -62.25 | -56.62 | -70.91 | -- | -- | -- | -2,015.62 | 25.09 | -- | 0.00 | -- | -- | -- | 2.77 | -- | -- | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.28bn | -2.34bn | 18.33bn | 208.00 | -- | 2.25 | -- | 2.92 | -46.93 | -46.93 | 125.40 | 160.66 | 0.434 | 1.69 | 2.94 | 30,201,920.00 | -16.12 | -- | -19.68 | -- | 55.73 | -- | -37.15 | -- | 2.83 | -- | 0.2166 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Oncolys Biopharma Inc | 31.38m | -1.91bn | 19.29bn | 34.00 | -- | 8.96 | -- | 614.52 | -94.41 | -94.41 | 1.53 | 86.36 | 0.015 | 0.00 | 0.2917 | 923,058.80 | -91.65 | -45.75 | -104.28 | -51.86 | 0.00 | 60.46 | -6,093.40 | -233.66 | 9.72 | -102.93 | 0.1442 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Astena Holdings Co Ltd | 53.39bn | 2.09bn | 20.94bn | 1.40k | 9.71 | 0.7086 | 4.55 | 0.3923 | 52.62 | 52.62 | 1,341.82 | 721.11 | 0.7976 | 3.29 | 2.69 | 38,024,920.00 | 3.12 | 2.49 | 5.76 | 4.44 | 34.11 | 25.33 | 3.91 | 2.32 | 0.879 | 391.65 | 0.349 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.02bn | 21.90bn | 44.00 | -- | 2.46 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | 0.00 | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | 0.00 | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 57.72bn | 2.20bn | 25.06bn | 1.31k | 10.30 | 0.5978 | 5.60 | 0.4342 | 257.39 | 257.39 | 6,774.96 | 4,436.49 | 0.7581 | 3.07 | 2.33 | 44,163,730.00 | 2.89 | 1.91 | 4.97 | 3.09 | 26.58 | 26.92 | 3.81 | 2.69 | 0.9406 | 50.75 | 0.267 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 03 Oct 2024 | 1.23m | 3.01% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 1.14m | 2.78% |
| Nikko Asset Management Co., Ltd.as of 04 Oct 2024 | 581.80k | 1.42% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2024 | 562.90k | 1.37% |
| SPARX Asset Management Co., Ltd.as of 24 Jul 2023 | 340.30k | 0.83% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 2024 | 247.40k | 0.60% |
| Dimensional Fund Advisors Ltd.as of 03 Oct 2024 | 94.95k | 0.23% |
| BlackRock Japan Co. Ltd.as of 03 Oct 2024 | 69.40k | 0.17% |
| Asset Management One Co., Ltd.as of 03 Oct 2024 | 58.70k | 0.14% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 03 Oct 2024 | 54.80k | 0.13% |
